Selected research
Industry Growth & Trends
Global Amoxicillin Drug Industry Growth and Trends Forecast to 2032
Market perspective
The global Amoxicillin Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Amoxicillin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Amoxicillin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Amoxicillin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Amoxicillin Drug include GSK, Teva, Novartis, Viatris, United Laboratories, Sun Pharma, NCPC, Meiji Holdings and LKPC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Amoxicillin Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Amoxicillin Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Amoxicillin Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Amoxicillin Drug.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Amoxicillin Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Amoxicillin Drug Market by Company
GSK
Teva
Novartis
Viatris
United Laboratories
Sun Pharma
NCPC
Meiji Holdings
LKPC
HPGC
Hikma
Dr. Reddy
CSPC
Cipla
Centrient Pharma
Aurubindo
Amoxicillin Drug Segment by Type
Capsule
Tablet
Other
Amoxicillin Drug Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Amoxicillin Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amoxicillin Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amoxicillin Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amoxicillin Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amoxicillin Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Amoxicillin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule
- Tablet
- Other
Applications
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Companies covered
- GSK
- Teva
- Novartis
- Viatris
- United Laboratories
- Sun Pharma
- NCPC
- Meiji Holdings
- LKPC
- HPGC
- Hikma
- Dr. Reddy
- CSPC
- Cipla
- Centrient Pharma
- Aurubindo
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Amoxicillin Drug Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Amoxicillin Drug Sales Estimates and Forecasts (2021-2032)
- 1.3 Amoxicillin Drug Market by Type
- 1.3.1 Capsule
- 1.3.2 Tablet
- 1.3.3 Other
- 1.4 Global Amoxicillin Drug Market Size by Type
- 1.4.1 Global Amoxicillin Drug Market Size Overview by Type (2021-2032)
- 1.4.2 Global Amoxicillin Drug Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Amoxicillin Drug Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Amoxicillin Drug Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Amoxicillin Drug Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Amoxicillin Drug Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Amoxicillin Drug Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Amoxicillin Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Amoxicillin Drug Industry Trends
- 2.2 Amoxicillin Drug Industry Drivers
- 2.3 Amoxicillin Drug Industry Opportunities and Challenges
- 2.4 Amoxicillin Drug Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Amoxicillin Drug Revenue (2021-2026)
- 3.2 Global Top Players by Amoxicillin Drug Sales (2021-2026)
- 3.3 Global Top Players by Amoxicillin Drug Price (2021-2026)
- 3.4 Global Amoxicillin Drug Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Amoxicillin Drug Major Company Production Sites & Headquarters
- 3.6 Global Amoxicillin Drug Company, Product Type & Application
- 3.7 Global Amoxicillin Drug Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Amoxicillin Drug Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Amoxicillin Drug Players Market Share by Revenue in 2025
- 3.8.3 2025 Amoxicillin Drug Tier 1, Tier 2, and Tier 3
4 Amoxicillin Drug Regional Status and Outlook
- 4.1 Global Amoxicillin Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Amoxicillin Drug Historic Market Size by Region
- 4.2.1 Global Amoxicillin Drug Sales in Volume by Region (2021-2026)
- 4.2.2 Global Amoxicillin Drug Sales in Value by Region (2021-2026)
- 4.2.3 Global Amoxicillin Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Amoxicillin Drug Forecasted Market Size by Region
- 4.3.1 Global Amoxicillin Drug Sales in Volume by Region (2027-2032)
- 4.3.2 Global Amoxicillin Drug Sales in Value by Region (2027-2032)
- 4.3.3 Global Amoxicillin Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Amoxicillin Drug by Application
- 5.1 Amoxicillin Drug Market by Application
- 5.1.1 Hospital Pharmacy
- 5.1.2 Online Pharmacy
- 5.1.3 Retail Pharmacy
- 5.2 Global Amoxicillin Drug Market Size by Application
- 5.2.1 Global Amoxicillin Drug Market Size Overview by Application (2021-2032)
- 5.2.2 Global Amoxicillin Drug Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Amoxicillin Drug Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Amoxicillin Drug Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Amoxicillin Drug Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Amoxicillin Drug Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Amoxicillin Drug Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Amoxicillin Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 GSK
- 6.1.1 GSK Company Information
- 6.1.2 GSK Business Overview
- 6.1.3 GSK Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 GSK Amoxicillin Drug Product Portfolio
- 6.1.5 GSK Recent Developments
- 6.2 Teva
- 6.2.1 Teva Company Information
- 6.2.2 Teva Business Overview
- 6.2.3 Teva Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Teva Amoxicillin Drug Product Portfolio
- 6.2.5 Teva Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Novartis Amoxicillin Drug Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 Viatris
- 6.4.1 Viatris Company Information
- 6.4.2 Viatris Business Overview
- 6.4.3 Viatris Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Viatris Amoxicillin Drug Product Portfolio
- 6.4.5 Viatris Recent Developments
- 6.5 United Laboratories
- 6.5.1 United Laboratories Company Information
- 6.5.2 United Laboratories Business Overview
- 6.5.3 United Laboratories Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 United Laboratories Amoxicillin Drug Product Portfolio
- 6.5.5 United Laboratories Recent Developments
- 6.6 Sun Pharma
- 6.6.1 Sun Pharma Company Information
- 6.6.2 Sun Pharma Business Overview
- 6.6.3 Sun Pharma Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Sun Pharma Amoxicillin Drug Product Portfolio
- 6.6.5 Sun Pharma Recent Developments
- 6.7 NCPC
- 6.7.1 NCPC Company Information
- 6.7.2 NCPC Business Overview
- 6.7.3 NCPC Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 NCPC Amoxicillin Drug Product Portfolio
- 6.7.5 NCPC Recent Developments
- 6.8 Meiji Holdings
- 6.8.1 Meiji Holdings Company Information
- 6.8.2 Meiji Holdings Business Overview
- 6.8.3 Meiji Holdings Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Meiji Holdings Amoxicillin Drug Product Portfolio
- 6.8.5 Meiji Holdings Recent Developments
- 6.9 LKPC
- 6.9.1 LKPC Company Information
- 6.9.2 LKPC Business Overview
- 6.9.3 LKPC Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 LKPC Amoxicillin Drug Product Portfolio
- 6.9.5 LKPC Recent Developments
- 6.10 HPGC
- 6.10.1 HPGC Company Information
- 6.10.2 HPGC Business Overview
- 6.10.3 HPGC Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 HPGC Amoxicillin Drug Product Portfolio
- 6.10.5 HPGC Recent Developments
- 6.11 Hikma
- 6.11.1 Hikma Company Information
- 6.11.2 Hikma Business Overview
- 6.11.3 Hikma Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Hikma Amoxicillin Drug Product Portfolio
- 6.11.5 Hikma Recent Developments
- 6.12 Dr. Reddy
- 6.12.1 Dr. Reddy Company Information
- 6.12.2 Dr. Reddy Business Overview
- 6.12.3 Dr. Reddy Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Dr. Reddy Amoxicillin Drug Product Portfolio
- 6.12.5 Dr. Reddy Recent Developments
- 6.13 CSPC
- 6.13.1 CSPC Company Information
- 6.13.2 CSPC Business Overview
- 6.13.3 CSPC Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 CSPC Amoxicillin Drug Product Portfolio
- 6.13.5 CSPC Recent Developments
- 6.14 Cipla
- 6.14.1 Cipla Company Information
- 6.14.2 Cipla Business Overview
- 6.14.3 Cipla Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Cipla Amoxicillin Drug Product Portfolio
- 6.14.5 Cipla Recent Developments
- 6.15 Centrient Pharma
- 6.15.1 Centrient Pharma Company Information
- 6.15.2 Centrient Pharma Business Overview
- 6.15.3 Centrient Pharma Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Centrient Pharma Amoxicillin Drug Product Portfolio
- 6.15.5 Centrient Pharma Recent Developments
- 6.16 Aurubindo
- 6.16.1 Aurubindo Company Information
- 6.16.2 Aurubindo Business Overview
- 6.16.3 Aurubindo Amoxicillin Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Aurubindo Amoxicillin Drug Product Portfolio
- 6.16.5 Aurubindo Recent Developments
7 North America by Country
- 7.1 North America Amoxicillin Drug Sales by Country
- 7.1.1 North America Amoxicillin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Amoxicillin Drug Sales by Country (2021-2026)
- 7.1.3 North America Amoxicillin Drug Sales Forecast by Country (2027-2032)
- 7.2 North America Amoxicillin Drug Market Size by Country
- 7.2.1 North America Amoxicillin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Amoxicillin Drug Market Size by Country (2021-2026)
- 7.2.3 North America Amoxicillin Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Amoxicillin Drug Sales by Country
- 8.1.1 Europe Amoxicillin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Amoxicillin Drug Sales by Country (2021-2026)
- 8.1.3 Europe Amoxicillin Drug Sales Forecast by Country (2027-2032)
- 8.2 Europe Amoxicillin Drug Market Size by Country
- 8.2.1 Europe Amoxicillin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Amoxicillin Drug Market Size by Country (2021-2026)
- 8.2.3 Europe Amoxicillin Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Amoxicillin Drug Sales by Country
- 9.1.1 Asia-Pacific Amoxicillin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Amoxicillin Drug Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Amoxicillin Drug Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Amoxicillin Drug Market Size by Country
- 9.2.1 Asia-Pacific Amoxicillin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Amoxicillin Drug Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Amoxicillin Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Amoxicillin Drug Sales by Country
- 10.1.1 South America Amoxicillin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Amoxicillin Drug Sales by Country (2021-2026)
- 10.1.3 South America Amoxicillin Drug Sales Forecast by Country (2027-2032)
- 10.2 South America Amoxicillin Drug Market Size by Country
- 10.2.1 South America Amoxicillin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Amoxicillin Drug Market Size by Country (2021-2026)
- 10.2.3 South America Amoxicillin Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Amoxicillin Drug Sales by Country
- 11.1.1 Middle East and Africa Amoxicillin Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Amoxicillin Drug Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Amoxicillin Drug Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Amoxicillin Drug Market Size by Country
- 11.2.1 Middle East and Africa Amoxicillin Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Amoxicillin Drug Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Amoxicillin Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Amoxicillin Drug Value Chain Analysis
- 12.1.1 Amoxicillin Drug Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Amoxicillin Drug Production Mode & Process
- 12.2 Amoxicillin Drug Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Amoxicillin Drug Distributors
- 12.2.3 Amoxicillin Drug Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst